Oral solid dosage forms containing the selective norepinephrine reuptake inhibitor for psychotherapeutic applications. Pharmaceutical manufacturers produce them for distribution to wholesalers, psychiatric hospitals, clinics, and retail pharmacies, where procurement professionals acquire them for mental health treatment protocols.